Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of RNA01:23

Types of RNA

61.1K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
61.1K
CRISPR and crRNAs02:53

CRISPR and crRNAs

14.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
14.5K
RNA Interference01:23

RNA Interference

24.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.2K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

3.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.1K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

94
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
94
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

933
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
933

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered gut symbionts mediate cross-phylum antagonism to suppress uropathogenic <i>Escherichia coli</i> colonization.

bioRxiv : the preprint server for biology·2026
Same author

Synthetic circuits for cell ratio control.

Nature·2026
Same author

Advances in biocontainment strategies of engineered microbes for use in humans.

Current opinion in microbiology·2026
Same author

Design principles for adaptive and evolving engineered living materials.

Current opinion in biotechnology·2025
Same author

Engineering butyrate-producing Lachnospiraceae to treat metabolic disease.

bioRxiv : the preprint server for biology·2025
Same author

Deep generative models design mRNA sequences with enhanced translational capacity and stability.

Science (New York, N.Y.)·2025
Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026
Same journal

Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

Nature biotechnology·2026
Same journal

Experiment-guided AlphaFold3 resolves measurement-consistent protein ensembles.

Nature biotechnology·2026
Same journal

Spatially resolved profiling of extracellular vesicles in tissues with Spatial-EV-seq.

Nature biotechnology·2026
Same journal

Mapping and engineering the human cell-cell interactome.

Nature biotechnology·2026
Same journal

Efficient generation of epitope-targeted antibodies with Germinal.

Nature biotechnology·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
08:25

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

Published on: March 20, 2016

14.7K

Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Robert J Citorik1, Mark Mimee1, Timothy K Lu2

  • 11] MIT Microbiology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [2] MIT Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Nature Biotechnology
|September 22, 2014
PubMed
Summary
This summary is machine-generated.

Researchers developed novel CRISPR-Cas based antimicrobials, RNA-guided nucleases (RGNs), to precisely target and eliminate specific bacteria, including drug-resistant strains, offering a customizable approach to combat infections and reshape microbial communities.

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

10.5K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Experiment Videos

Last Updated: Apr 23, 2026

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
08:25

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli

Published on: March 20, 2016

14.7K
Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

10.5K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biotechnology

Background:

  • Conventional antibiotics exhibit broad-spectrum activity, leading to collateral damage to beneficial bacteria and promoting antimicrobial resistance.
  • There is a critical need for targeted antimicrobial strategies to overcome resistance and preserve microbial ecosystems.

Purpose of the Study:

  • To engineer CRISPR-Cas based RNA-guided nucleases (RGNs) as customizable antimicrobials with designed spectra of activity.
  • To evaluate the efficacy of RGNs in eliminating specific bacterial pathogens and modulating complex microbial populations.

Main Methods:

  • Designing RGNs to target specific DNA sequences, including antibiotic resistance and virulence genes.
  • Delivering RGNs to bacterial populations via bacteriophages or conjugative plasmids.
  • Assessing RGN efficacy in a Galleria mellonella infection model and in modulating bacterial communities.

Main Results:

  • RGN delivery significantly improved survival rates in a Galleria mellonella infection model.
  • RGNs effectively targeted and reduced specific bacterial strains, including carbapenem-resistant Enterobacteriaceae and enterohemorrhagic Escherichia coli.
  • Selective knockdown of targeted strains based on genetic signatures was demonstrated in complex bacterial populations.

Conclusions:

  • RNA-guided nucleases (RGNs) represent a new class of highly discriminatory and customizable antimicrobials.
  • RGNs exert selective pressure at the DNA level, reducing undesired genes and minimizing off-target effects.
  • This technology enables programmable remodeling of microbiota and offers a precise alternative to broad-spectrum antibiotics.